LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMFA04010061
|
ent-4-epi-11-F4t-NeuroP
|
3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010062
|
ent-11-F4c-NeuroP
|
3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010063
|
11-epi-11-F4c-NeuroP
|
3-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010064
|
4,11-diepi-11-F4t-NeuroP
|
3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010065
|
4,11-diepi-11-F4c-NeuroP
|
3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010066
|
11-epi-11-F4t-NeuroP
|
3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010067
|
ent-11-epi-4-Ft-NeuroP
|
3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010068
|
ent-4,11-diepi-4-Fc-NeuroP
|
3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010069
|
ent-4,11-diepi-4-Ft-NeuroP
|
3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010070
|
ent-11-epi-4-Fc-NeuroP
|
3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010071
|
11-F4c-NeuroP
|
3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010072
|
4-epi-11-F4t-NeuroP
|
3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010073
|
4-epi-11-F4c-NeuroP
|
3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010074
|
11-F4t-NeuroP
|
3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010075
|
ent-13-F4t-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010076
|
ent-16-epi-13-F4c-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010077
|
ent-16-epi-13-F4t-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010078
|
ent-13-F4c-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010080
|
13,16-diepi-13-F4t-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010081
|
13,16-diepi-13-F4c-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010082
|
13-epi-13-F4t-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010088
|
16-epi-13-F4t-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010089
|
16-epi-13-F4c-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010090
|
13-F4t-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010091
|
ent-14-F4t-NeuroP
|
(Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010092
|
ent-7-epi-14-F4c-NeuroP
|
(Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010093
|
ent-7-epi-14-F4t-NeuroP
|
(Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010094
|
ent-14-F4c-NeuroP
|
(Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010095
|
ent-14-epi-14-F4t-NeuroP
|
(Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010096
|
ent-7,14-diepi-14-F4c-NeuroP
|
(Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010011
|
ent-4-F4t-NeuroP
|
(R,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010029
|
ent-10-epi-7-F4t-NeuroP
|
(R,4Z,8E)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010054
|
ent-10-epi-4-Fc-NeuroP
|
(S,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010079
|
13-epi-13-F4c-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010083
|
ent-13-epi-13-F4t-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010097
|
ent-7,14-diepi-14-F4t-NeuroP
|
(Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010098
|
ent-14-epi-14-F4t-NeuroP
|
(Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010099
|
14-epi-14-F4c-NeuroP
|
(Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010100
|
7,14-diepi-14-F4t-NeuroP
|
(Z)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010101
|
7,14-diepi-14-F4c-NeuroP
|
(Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010102
|
14-epi-14-F4t-NeuroP
|
(Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010103
|
14-F4c-NeuroP
|
(Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010105
|
7-epi-14-F4c-NeuroP
|
(Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010106
|
14-F4t-NeuroP
|
(Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010107
|
ent-17-F4t-NeuroP
|
(4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010108
|
ent-10-epi-17-F4c-NeuroP
|
(4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010109
|
ent-10-epi-17-F4t-NeuroP
|
(4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010110
|
ent-17-F4c-NeuroP
|
(4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010111
|
ent-17-epi-17-F4t-NeuroP
|
(4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
LMFA04010112
|
ent-10,17-diepi-17-F4c-NeuroP
|
(4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|